CIM Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,370
Closed -$214K 312
2021
Q3
$214K Hold
2,370
0.07% 272
2021
Q2
$226K Hold
2,370
0.07% 269
2021
Q1
$270K Buy
2,370
+853
+56% +$97.2K 0.09% 225
2020
Q4
$210K Buy
+1,517
New +$210K 0.07% 268
2020
Q1
Sell
-4,780
Closed -$204K 227
2019
Q4
$204K Buy
+4,780
New +$204K 0.08% 209